Spbniivs will Fund research of a vaccine against Haemophilus influenzae

Saint-Petersburg Institute of vaccines and serums FMBA Russia (Spbniivs) will be spent 97 million rubles for the conduct of clinical trials of vaccines to prevent infections caused by Haemophilus influenzae.

“The organization and conduct of efficacy and safety of vaccines for prevention of Haemophilus influenzae Baby-Hib, lyophilisate for solution preparation for intramuscular injection, 0.5 ml in the framework of the phase II clinical study involving healthy volunteers 3 months. – 5 years, the initial price of the contract is 97 million rubles,” – writes TASS with reference to the materials of bids for state procurement.

Vaccine Baby-Hib develops Spbniivs. Stated in the competition period of the clinical trials of 448 days from the date of signing of the contract.

Leave a Reply

Your email address will not be published. Required fields are marked *

Releated

For the six months Kurgan “Synthesis” increased revenue by 42%

Revenue of JSC “Sintez” (part of the Allium Group) for 6 months of 2020 has increased by 42% year-on-year to 6,767 billion. Net profit reached 752.9 million roubles that on 23% more than in the same period last year. Export sales grew by 36% year-on-year, exceeding 1 billion rubles, told in the company. Secondary sales […]

Russia confirmed on 5 065 new cases COVID-19

In recent days in Russia identified 5 065 new cases of coronavirus in 83 regions. Died 114 people, fully recovered 6 568 patients. In Moscow confirmed 688 new cases of coronavirus. The average rate of increase of new cases for the first two weeks of August is 0.28%. This figure compares with the first two […]